122 related articles for article (PubMed ID: 8761599)
1. [Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
Gérard A; Le Meins V; Maurer P; Witz B; Dopff C
Pathol Biol (Paris); 1996 Feb; 44(2):138-40. PubMed ID: 8761599
[TBL] [Abstract][Full Text] [Related]
2. Treating serious infections: focus on cefepime.
Wong-Beringer A
Pharmacotherapy; 2004 Dec; 24(12 Pt 2):216S-23S. PubMed ID: 15585451
[TBL] [Abstract][Full Text] [Related]
3. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Chaudhary M; Shrivastava SM; Varughese L; Sehgal R
Curr Clin Pharmacol; 2008 May; 3(2):118-22. PubMed ID: 18700304
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
[TBL] [Abstract][Full Text] [Related]
6. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
May T; Janbon F; Beuscart C; Meyran M; Roue R
Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
[TBL] [Abstract][Full Text] [Related]
7. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
Bow EJ; Rotstein C; Noskin GA; Laverdiere M; Schwarer AP; Segal BH; Seymour JF; Szer J; Sanche S
Clin Infect Dis; 2006 Aug; 43(4):447-59. PubMed ID: 16838234
[TBL] [Abstract][Full Text] [Related]
9. Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Steyaert S; Peleman R; Vaneechoutte M; De Baere T; Claeys G; Verschraegen G
J Clin Microbiol; 1999 Nov; 37(11):3778-9. PubMed ID: 10523601
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer.
Fujita M; Ouchi H; Inoue Y; Inoshima I; Ohshima T; Yoshimura C; Wataya H; Kawasaki M; Tokunaga S; Nakanishi Y;
J Infect Chemother; 2010 Apr; 16(2):113-7. PubMed ID: 20130951
[TBL] [Abstract][Full Text] [Related]
11. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH
Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Ohyashiki K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
15. A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Gouin F; Papazian L; Martin C; Albanese J; Durbec O; Domart Y; Veyssier P; Leroy J; Grès JJ; Rollin C
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():205-14. PubMed ID: 8150764
[TBL] [Abstract][Full Text] [Related]
16. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Yakovlev SV; Stratchounski LS; Woods GL; Adeyi B; McCarroll KA; Ginanni JA; Friedland IR; Wood CA; DiNubile MJ
Eur J Clin Microbiol Infect Dis; 2006 Oct; 25(10):633-41. PubMed ID: 17024505
[TBL] [Abstract][Full Text] [Related]
17. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
18. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
19. High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Goethaert K; Van Looveren M; Lammens C; Jansens H; Baraniak A; Gniadkowski M; Van Herck K; Jorens PG; Demey HE; Ieven M; Bossaert L; Goossens H
Clin Microbiol Infect; 2006 Jan; 12(1):56-62. PubMed ID: 16460547
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
